<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(14)</volume><submitter>Grigoruta M</submitter><funding>DOD Peer Reviewed Cancer Research Program Idea Award</funding><funding>NIH SURE R16</funding><funding>University Research Institute (URI) Award</funding><funding>School of Pharmacy at the University of Texas at El Paso</funding><funding>Lizanell and Colbert Coldwell Foundation (FNDN)</funding><journal>Journal of clinical medicine</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12295115</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Advances and Challenges in Immunotherapy for Metastatic Uveal Melanoma: Clinical Strategies and Emerging Targets</pubmed_title><pmcid>PMC12295115</pmcid><funding_grant_id>R16GM145559</funding_grant_id><funding_grant_id>W81XWH-19-1-0282</funding_grant_id><funding_grant_id>14648680</funding_grant_id><pubmed_authors>Qin Y</pubmed_authors><pubmed_authors>Grigoruta M</pubmed_authors><pubmed_authors>Kong X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Advances and Challenges in Immunotherapy for Metastatic Uveal Melanoma: Clinical Strategies and Emerging Targets</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2025-08-13T03:04:22.14Z</modification><creation>2025-08-13T03:04:22.14Z</creation></dates><accession>S-EPMC12295115</accession><cross_references/></HashMap>